Brain-Computer Interface Becomes Reality: Five Concept Stocks Attract Over 100 Institutional Investors Amid IPO Filings

Source: Securities Times

People's Finance News, March 24th: According to the National Healthcare Security Administration (NHSA), on March 13th, the world’s first invasive brain-computer interface medical device was officially approved for marketing. On March 15th, the NHSA took the initiative to connect and provide upfront services, completing the assignment of a medical insurance code for the product. This successfully facilitated a key step for the innovative product from regulatory approval to clinical application, marking that the brain-computer interface industry has officially shifted from the "planning blueprint" phase into the "fast lane of implementation."

According to statistics from the Securities Times·Data Treasure, since the beginning of this year, 12 brain-computer interface concept stocks have been surveyed by institutions. Among them, five stocks were surveyed by more than 110 institutions, respectively.Sunnyou、Jiangsu Apon Medical Technology Co., Ltd.、Entrop Tech、Biotest BiotechAnd37 Interactive Entertainment(Maintenance of Rights)。

As of the closing on March 23, the total A-share market value of brain-computer interface concept stocks was 475.497 billion yuan. Since the beginning of this year, the overall pullback of brain-computer interface concept stocks has been significant, with an average pullback of 30.96% when comparing the closing price on March 23 to the year's high.Haige Communications、Pulit, Xiangyu Medical, Biotest Biotech among the top in pullback magnitude.